Nėra interneto ryšio – rodoma išsaugota puslapio versija.

IQVIA Holdings In…

USUSD
← Į Akcijų Filtrą
US:IQVLSE:0JDM

IQVIA Holdings Inc (LSE:0JDM) — Biotechnology: Commercial Physical & Biological Resarch. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 2. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie Įmonę

Svetainė
iqvia.com
Investuotojams
ir.iqvia.com/
Sektorius
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Būstinė
Durham, United States
Generalinis Direktorius
Ari Bousbib
Darbuotojai
94 000
Įkurta
2016
Biržoje Nuo
29.01.2018 (LSE:0JDM)
Apyvartoje Esančios Akcijos
164.6 mln. 2026-07-21 duomenimis
Laisvai Apyvartinės Akcijos
156.25 mln.
Rinkos Kapitalizacija
44.25 mlrd. USD
Insaideriai
1.09%
Instituciniai Investuotojai
103.42%
Šaka (SIC)
Services-Commercial Physical & Biological Research
ISIN
US46266C1053
LEI
549300W3R20NM4KQPH86
P/E
47.1
Išmokų Santykis
41.0%
FCF
2.12 mlrd. USD
Išmokėjimas / FCF
27%
Skola
15.8 mlrd. USD
6.6 m. FCF
Dividendų Stažas
—
Pelnas, FCF ir dividendai – už 12 mėnesių iki 31.03.2026 (naujausia įmonės ataskaita).
NAV
37.27 USD · P/NAV 7.00
Balanso Data31.03.2026
Turtas29.7 mlrd. USD
− Įsipareigojimai23.3 mlrd. USD
= Nuosavas Kapitalas iš Viso6.35 mlrd. USD
− Nekontroliuojančiosios Dalys128 mln. USD
= NAV (įmonės akcininkų nuosavas kapitalas)6.22 mlrd. USD
− Prestižas16.5 mlrd. USD
− Nematerialusis Turtas4.80 mlrd. USD
= Materialioji NAV−15.1 mlrd. USD
Akcijos166 900 000
NAV Vienai Akcijai37.27 USD
Apčiuopiamoji NAV Vienai Akcijai−90.63 USD
Akcijos Kaina (0JDM)261.01 USD
P/NAV7.00
NAV Istorija
Balanso DataNAVNAV Vienai Akcijai
31.03.20266.22 mlrd. USD37.27 USD
31.12.20256.50 mlrd. USD38.34 USD
30.09.20256.16 mlrd. USD36.17 USD
30.06.20255.78 mlrd. USD33.99 USD
31.03.20255.98 mlrd. USD34.33 USD
31.12.20246.07 mlrd. USD34.45 USD
30.09.20246.97 mlrd. USD38.36 USD
30.06.20246.71 mlrd. USD36.83 USD
Aprašymas

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

reklama

Biržos ir Tikeriai

BiržaTikerisValiutaKainaTipas
US USA StocksIQV pagrindinisUSD271.04 +3.45%paprastosios akcijos
LSE London Stock Exchange0JDM IOBUSD261.01 +0.00%paprastosios akcijos

Kaina per 3 Mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Dividendų išmokų nerasta (patikrinta 17.10.2026). Įmonė greičiausiai nemoka dividendų.

Šios Savaitės Naujienos

Pranešimai spaudai iš įmonės investuotojų svetainės, atnaujinami kasdien. Nuorodos veda į įmonės svetainę. Antraštės pateikiamos originalo kalba, kaip įmonės svetainėje.

Didžiausi Akcininkai

TurėtojasDalisAkcijosAtaskaitos Data
Blackrock Inc.8.84%14.55 mln.2026-06-30
Harris Associates L.P.7.4%12.18 mln.2026-06-30
Vanguard Capital Managem…6.63%10.91 mln.2026-06-30
State Street Corporation4.56%7.51 mln.2026-06-30
Vanguard Portfolio Manag…4.56%7.5 mln.2026-06-30
JPMORGAN CHASE & CO3.73%6.14 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…3.22%5.3 mln.2026-06-30
Artisan Partners Limited…2.88%4.74 mln.2026-06-30
Boston Partners2.71%4.47 mln.2026-06-30
Geode Capital Management…2.71%4.45 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.63%4.32 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.2%3.62 mln.2026-06-30
Invesco Ltd.1.99%3.28 mln.2026-06-30
HARRIS ASSOCIATES INVEST…1.58%2.61 mln.2026-06-30
HARRIS ASSOCIATES INVEST…1.56%2.57 mln.2026-06-30
iShares Trust-iShares Co…1.35%2.22 mln.2026-08-31
Fidelity Concord Street…1.31%2.16 mln.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.24%2.04 mln.2026-08-31
VANGUARD WINDSOR FUNDS-V…1.07%1.76 mln.2026-07-31
VANGUARD INDEX FUNDS-Van…0.96%1.59 mln.2026-06-30
BOUSBIB ARI B (Chief Exe…≈0.84%1.38 mln.2026-07-29
BRUEHLMAN RONALD E (Chie…≈0.03%55 9962026-02-06
HAAS BERND (Officer)≈0.01%24 4142026-02-06
GRENFELL ALISTAIR (Offic…≈0.01%24 1242026-02-06
SHERBET ERIC M (General…≈0.01%20 9992026-07-29
LEONARD JOHN M (Director…≈0.01%16 9462026-04-23
GOGGINS COLLEEN A (Direc…≈0.01%14 4532026-04-23
STAUB WALTER. RICHARD II…≈0.01%13 3122026-08-03
FEDOCK MICHAEL J. (Offic…≈0.01%9 5952026-02-06
DANHAKL JOHN G (Director…——2026-04-23